Table 2.
Number of Patients Treated with First, and Second-line TKIs.
| 2nd line TKI | ||||||
|---|---|---|---|---|---|---|
| no change | Imatinib | Nilotnib | Dasatinib | Bostinib | ||
| 1st line TKI (number of patients) |
Imatinib (170) | 109 | - | 36 | 25 | 0 |
| Nilotnib (41) | 31 | 4 | - | 5 | 1 | |
| Dasatinib (52) | 44 | 3 | 5 | - | 0 | |
| Bostinib (1) | 1 | 0 | 0 | 0 | - | |
TKI: tyrosine kinase inhibitor